139 related articles for article (PubMed ID: 2790989)
1. [Magistral preparation of methylene diphosphonate and its clinical evaluation in radionuclide diagnosis of the skeleton].
Lepej J; Marosová A; Altmann P; Reznák I; Podmajerský M
Cesk Farm; 1989 Jul; 38(5):204-9. PubMed ID: 2790989
[TBL] [Abstract][Full Text] [Related]
2. Electrophoretic analysis of different technetium-99m (SnCl2) methylene diphosphonate complexes.
Najafi A; Hutchison N
J Nucl Med; 1985 May; 26(5):524-30. PubMed ID: 3157787
[TBL] [Abstract][Full Text] [Related]
3. Diffuse abdominal uptake of technetium-99m-methylene diphosphonate in a patient on continuous ambulatory dialysis during bone scintigraphy.
McDevitt GR; Heironimus JD; Toney MO; Billingsley JL
J Nucl Med; 1992 Nov; 33(11):2052-4. PubMed ID: 1432173
[TBL] [Abstract][Full Text] [Related]
4. Quantitative measurements of bone remodeling using 99mTc-methylene diphosphonate bone scans and blood sampling.
Moore AE; Blake GM; Fogelman I
J Nucl Med; 2008 Mar; 49(3):375-82. PubMed ID: 18287266
[TBL] [Abstract][Full Text] [Related]
5. [Cardiac involvement in systemic amyloidosis: myocardial scintigraphic evaluation].
Hongo M; Yamada H; Okubo S; Hirayama J; Fujii T; Kusama S; Ikeda S
J Cardiogr; 1985 Mar; 15(1):163-80. PubMed ID: 2999267
[TBL] [Abstract][Full Text] [Related]
6. Validation of a blood-sampling method for the measurement of 99mTc-methylene diphosphonate skeletal plasma clearance.
Moore AE; Blake GM; Fogelman I
J Nucl Med; 2006 Apr; 47(4):581-6. PubMed ID: 16595490
[TBL] [Abstract][Full Text] [Related]
7. [Quantitative whole-body bone scintigraphy. II. Pharmacokinetics of osteotropic radiopharmaceuticals (author's transl)].
Anger K; Aigner S; Bühler M; Umbach I
Nuklearmedizin; 1980 Jul; 19(3):97-107. PubMed ID: 7465432
[TBL] [Abstract][Full Text] [Related]
8. Soft tissue uptake on 99mTc methylene diphosphonate bone scan imaging: pictorial review.
Kaye J; Hayward M
Australas Radiol; 2002 Mar; 46(1):13-21. PubMed ID: 11966582
[TBL] [Abstract][Full Text] [Related]
9. Quantitative studies of bone in postmenopausal women using (18)F-fluoride and (99m)Tc-methylene diphosphonate.
Blake GM; Park-Holohan SJ; Fogelman I
J Nucl Med; 2002 Mar; 43(3):338-45. PubMed ID: 11884493
[TBL] [Abstract][Full Text] [Related]
10. A comparison of bone imaging with Tc-99m DPD and Tc-99m MDP: concise communication.
Buell U; Kleinhans E; Zorn-Bopp E; Reuschel W; Muenzing W; Moser EA; Seiderer M
J Nucl Med; 1982 Mar; 23(3):214-7. PubMed ID: 6460854
[TBL] [Abstract][Full Text] [Related]
11. Idiopathic hepatic uptake of (99m)Tc methylene diphosphonate: a case report.
MacDonald J
J Nucl Med Technol; 2001 Mar; 29(1):32-6. PubMed ID: 11283215
[TBL] [Abstract][Full Text] [Related]
12. Quantitative studies of bone using (18)F-fluoride and (99m)Tc-methylene diphosphonate: evaluation of renal and whole-blood kinetics.
Park-Holohan SJ; Blake GM; Fogelman I
Nucl Med Commun; 2001 Sep; 22(9):1037-44. PubMed ID: 11505214
[TBL] [Abstract][Full Text] [Related]
13. Tc-99m hydroxymethylene diphosphonate and Tc-99m methylene diphosphonate: biological and clinical comparison: concise communication.
Littlefield JL; Rudd TG
J Nucl Med; 1983 Jun; 24(6):463-6. PubMed ID: 6222166
[TBL] [Abstract][Full Text] [Related]
14. Bone scintigraphy with 99mTc-MDP formulated by a novel, simple and rapid sonication method: clinical results.
Goomer NC; Duggal RK; Prakash R
Eur J Nucl Med; 1999 Dec; 26(12):1633-4. PubMed ID: 10638421
[No Abstract] [Full Text] [Related]
15. A computer assisted comparison of 99Tcm-methylene-diphosphonate and 99Tcm-pyrophosphate bone imaging.
Büll U; Pfeifer JP; Niendorf HP; Tongendorff J
Br J Radiol; 1977 Sep; 50(597):629-36. PubMed ID: 198055
[TBL] [Abstract][Full Text] [Related]
16. Tc-99m HMDP (hydroxymethylene diphosphonate): a radiopharmaceutical for skeletal and acute myocardial infarct imaging. II. Comparison of Tc-99m hydroxymethylene diphosphonate (HMDP) with other technetium-labeled bone-imaging agents in a canine model.
Bevan JA; Tofe AJ; Benedict JJ; Francis MD; Barnett BL
J Nucl Med; 1980 Oct; 21(10):967-70. PubMed ID: 6252299
[TBL] [Abstract][Full Text] [Related]
17. Clinical significance of technetium-99m methylene diphosphonate myocardial uptake: association with carcinoma of the prostate.
al-Nahhas AM; Jinnouchi S; Anagnostopoulos C; Hirsch W; Heary T; McCready VR
Eur J Nucl Med; 1995 Feb; 22(2):148-53. PubMed ID: 7758502
[TBL] [Abstract][Full Text] [Related]
18. A rare case of polyostotic fibrous dysplasia assessed by bone scintigraphy with Tc-99m methylene diphosphonate (MDP).
Di Leo C; Ardemagni A; Bestetti A; Tagliabue L; Del Sole A; Conte A; Tarolo GL
Nuklearmedizin; 1999; 38(5):169-71. PubMed ID: 10488486
[TBL] [Abstract][Full Text] [Related]
19. Soft-tissue uptake of technetium-99m-MDP after prostate cryoablation.
Zucker I; Charkes ND; Seidmon EJ; Maurer AH
J Nucl Med; 1997 Apr; 38(4):525-8. PubMed ID: 9098195
[TBL] [Abstract][Full Text] [Related]
20. Influence of low grade exercise on skeletal scintigraphy using Tc-99m methylene diphosphonate.
Amin A; El-Kareem MA; Yahia AB
Nucl Med Rev Cent East Eur; 2015; 18(2):61-4. PubMed ID: 26315864
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
